vs
Side-by-side financial comparison of ARGENX SE (ARGX) and Vertiv Holdings Co (VRT). Click either name above to swap in a different company.
Vertiv Holdings Co is the larger business by last-quarter revenue ($2.6B vs $2.5B, roughly 1.1× ARGENX SE). ARGENX SE runs the higher net margin — 35.5% vs 14.7%, a 20.7% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 30.1%). Vertiv Holdings Co produced more free cash flow last quarter ($652.8M vs $322.4M).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Vertiv is an American multinational provider of critical infrastructure and services for data centers, communication networks, and commercial and industrial environments.
ARGX vs VRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $2.6B |
| Net Profit | $877.2M | $390.1M |
| Gross Margin | 89.5% | 37.7% |
| Operating Margin | 28.9% | — |
| Net Margin | 35.5% | 14.7% |
| Revenue YoY | 83.2% | 30.1% |
| Net Profit YoY | 1.3% | — |
| EPS (diluted) | $13.25 | $0.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.6B | ||
| Q4 25 | $2.5B | $2.9B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | $1.8B | $2.6B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $1.4B | $2.3B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | $901.9M | $2.0B |
| Q1 26 | — | $390.1M | ||
| Q4 25 | $877.2M | $445.6M | ||
| Q3 25 | — | $398.5M | ||
| Q2 25 | $414.8M | $324.2M | ||
| Q1 25 | — | $164.5M | ||
| Q4 24 | $865.6M | $147.0M | ||
| Q3 24 | — | $176.6M | ||
| Q2 24 | $-32.5M | $178.1M |
| Q1 26 | — | 37.7% | ||
| Q4 25 | 89.5% | 38.9% | ||
| Q3 25 | — | 37.8% | ||
| Q2 25 | 89.2% | 34.0% | ||
| Q1 25 | — | 33.7% | ||
| Q4 24 | 90.2% | 37.1% | ||
| Q3 24 | — | 36.5% | ||
| Q2 24 | 89.4% | 38.0% |
| Q1 26 | — | — | ||
| Q4 25 | 28.9% | 20.1% | ||
| Q3 25 | — | 19.3% | ||
| Q2 25 | 19.2% | 16.8% | ||
| Q1 25 | — | 14.3% | ||
| Q4 24 | 8.7% | 19.5% | ||
| Q3 24 | — | 17.9% | ||
| Q2 24 | -15.4% | 17.2% |
| Q1 26 | — | 14.7% | ||
| Q4 25 | 35.5% | 15.5% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | 23.4% | 12.3% | ||
| Q1 25 | — | 8.1% | ||
| Q4 24 | 64.1% | 6.3% | ||
| Q3 24 | — | 8.5% | ||
| Q2 24 | -3.6% | 9.1% |
| Q1 26 | — | $0.99 | ||
| Q4 25 | $13.25 | $1.14 | ||
| Q3 25 | — | $1.02 | ||
| Q2 25 | $6.32 | $0.83 | ||
| Q1 25 | — | $0.42 | ||
| Q4 24 | $13.33 | $0.38 | ||
| Q3 24 | — | $0.46 | ||
| Q2 24 | $-0.55 | $0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $2.5B |
| Total DebtLower is stronger | — | $0 |
| Stockholders' EquityBook value | $7.3B | $4.2B |
| Total Assets | $8.7B | $13.4B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.5B | ||
| Q4 25 | $3.5B | $1.7B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $2.1B | $1.6B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | $1.5B | $1.2B | ||
| Q3 24 | — | $908.7M | ||
| Q2 24 | $1.4B | $579.7M |
| Q1 26 | — | $0 | ||
| Q4 25 | — | $2.9B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | $11.0M | $2.9B |
| Q1 26 | — | $4.2B | ||
| Q4 25 | $7.3B | $3.9B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | $6.1B | $3.1B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | $5.5B | $2.4B | ||
| Q3 24 | — | $1.8B | ||
| Q2 24 | $4.3B | $1.5B |
| Q1 26 | — | $13.4B | ||
| Q4 25 | $8.7B | $12.2B | ||
| Q3 25 | — | $10.8B | ||
| Q2 25 | $7.2B | $10.4B | ||
| Q1 25 | — | $9.5B | ||
| Q4 24 | $6.2B | $9.1B | ||
| Q3 24 | — | $8.9B | ||
| Q2 24 | $4.8B | $8.1B |
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.83× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | — | 1.20× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | 0.00× | 1.91× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | — |
| Free Cash FlowOCF − Capex | $322.4M | $652.8M |
| FCF MarginFCF / Revenue | 13.0% | 24.6% |
| Capex IntensityCapex / Revenue | 0.0% | 4.2% |
| Cash ConversionOCF / Net Profit | 0.37× | — |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | $2.3B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $323.3M | $978.9M | ||
| Q3 25 | — | $508.7M | ||
| Q2 25 | $361.8M | $322.9M | ||
| Q1 25 | — | $303.3M | ||
| Q4 24 | $41.9M | $425.2M | ||
| Q3 24 | — | $378.2M | ||
| Q2 24 | $-124.7M | $378.4M |
| Q1 26 | — | $652.8M | ||
| Q4 25 | $322.4M | $885.6M | ||
| Q3 25 | — | $463.5M | ||
| Q2 25 | $356.6M | $277.9M | ||
| Q1 25 | — | $266.8M | ||
| Q4 24 | $40.9M | $364.5M | ||
| Q3 24 | — | $341.8M | ||
| Q2 24 | $-125.5M | $344.3M |
| Q1 26 | — | 24.6% | ||
| Q4 25 | 13.0% | 30.8% | ||
| Q3 25 | — | 17.3% | ||
| Q2 25 | 20.1% | 10.5% | ||
| Q1 25 | — | 13.1% | ||
| Q4 24 | 3.0% | 15.5% | ||
| Q3 24 | — | 16.5% | ||
| Q2 24 | -13.9% | 17.6% |
| Q1 26 | — | 4.2% | ||
| Q4 25 | 0.0% | 3.2% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | 0.3% | 1.7% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | 0.1% | 2.6% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | 0.1% | 1.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.37× | 2.20× | ||
| Q3 25 | — | 1.28× | ||
| Q2 25 | 0.87× | 1.00× | ||
| Q1 25 | — | 1.84× | ||
| Q4 24 | 0.05× | 2.89× | ||
| Q3 24 | — | 2.14× | ||
| Q2 24 | — | 2.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
